ID
30592
Description
Study part: Vital Signs (VS) Day 7, 10. A phase 1 single-masked, randomized (with respect to placebo), placebo-controlled, parallel-group, dose-rising study to evaluate the safety, tolerability and pharmacokinetics of repeat oral doses of GW786034 in elderly healthy volunteers. Trade Name: Votrient. Clinical Study ID: MD1103367.
Keywords
Versions (1)
- 6/17/18 6/17/18 -
Copyright Holder
GlaxoSmithKline
Uploaded on
June 17, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Vital Signs (VS) Day 7, 10 Pazopanib Macular Degeneration MD1103367
Vital Signs (VS) Day 7, 10
- StudyEvent: ODM
Similar models
Vital Signs (VS) Day 7, 10
- StudyEvent: ODM
C1262869 (UMLS CUI [1,2])
(Comment:en)
(Comment:en)
(Comment:en)